Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES) PBMTC SUP1701
Other Hematopoietic | Pediatrics
What is the purpose of this trial?
The purpose of this study is to evaluate whether virus-specific T cell lines (VSTs) are safe and can effectively control three viruses (EBV, CMV, and adenovirus) in patients who have had a stem cell transplant and also in patients that have a primary immunodeficiency disorder with no prior stem cell transplant.
- Trial withPediatric Blood and Marrow Transplant Consortium
- Start Date08/22/2019
- End Date02/27/2022
- Last Updated10/02/2019
- Study HIC#2000023146